How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst for 20+ years. He is a Chartered Market Technician ...
News headlines Recursion Pharmaceuticals reported mixed Q2 results, showing a revenue decline of 60% year-over-year while announcing significant clinical milestones. Despite a narrowed net loss, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results